Our results show that low-risk breast cancer patients have significantly higher immune scores and the increased infiltration of immune cells like CD8+ T cells, follicular helper T cells, and plasma cells, which indicated a more active immune response in the tumor microenvironment. The gene discussed is CD8A; the disease is breast cancer.